EPA TRI Facility · Chemicals

Janssen Pharmaceuticals Inc.

Athens, GA · Parent: Johnson & Johnson Inc

Total releases
72.4K lbs
Chemicals reported
10
Carcinogens
2
Primary pathway
Air Releases
Verify at EPA TRI →

Janssen Pharmaceuticals Inc. has reported 72.4K lbs of toxic releases across 10 chemicals to the EPA Toxic Release Inventory, based on annual facility disclosures from 2019 through 2023. Of the chemicals reported, 2 are classified as carcinogens, representing 20% of the facility's chemical profile. The facility operates in the Chemicals sector. The primary release pathway is air releases, accounting for 100% of total releases. All release data shown below is self-reported to the EPA under the Emergency Planning and Community Right-to-Know Act (EPCRA) Section 313.

#5,292 of 25,902 TRI facilities nationwide by total reported releases. Ranking reflects reported pounds, not toxicity or health risk.

Janssen Pharmaceuticals Inc. files annual Form R disclosures to the EPA Toxics Release Inventory under EPCRA Section 313, classified under NAICS 325411 (Chemicals). Across 5 years of records spanning 2019–2023, the site has disclosed 72.4K lbs in cumulative toxic releases across 10 distinct chemicals, 2 of which (20%) carry a carcinogenic classification.

The dominant release pathway is air releases at 72.4K lbs (100.0% of total volume). Between 2019 and 2023, reported totals increased by 17% - from 12.2K lbs to 14.3K lbs. The facility is operated under parent company Johnson & Johnson Inc.

TRI Form R values are self-reported estimates, not measured stack emissions, and treat every pound of reported chemical equally regardless of toxicity. Inclusion in the TRI database does not establish a health risk to nearby residents; it documents the annual reporting record that Janssen Pharmaceuticals Inc. has filed with the EPA under federal community right-to-know requirements.

Quick Facts

Industry
Chemicals
NAICS Code
325411
Total Releases
72.4K lbs
Chemicals Reported
10
Latest Report Year
2023

Compare this facility

See how Janssen Pharmaceuticals Inc. stacks up against nearby facilities and the typical reporter.

Total reported releases
Janssen Pharmaceuticals Inc.
72.4K lbs
Rayonier Performance Fibers Jesup Mill
22.6M lbs

100% less than the comparison

Chemicals reported
Janssen Pharmaceuticals Inc.
10
Rayonier Performance Fibers Jesup Mill
26

62% less than the comparison

Comparison reflects reported pounds and chemical counts, not toxicity or health risk. Averages cover facilities reporting any release.

How does this facility release toxic chemicals?

How Janssen Pharmaceuticals Inc. releases toxic chemicals into the environment. Total: 72.4K lbs.

Air Releases 72.4K lbs (100.0%)
View 5-Year Emissions Trend →

Emissions Trend Summary

From 2019 to 2023, total releases increased by 17% (12.2K lbs to 14.3K lbs).

Reported total releases by year

Janssen Pharmaceuticals Inc. - annual TRI totals

million lbs

What this shows Year-over-year reported totals. TRI figures are self-reported estimates and can swing with production levels, waste-rock handling and reporting changes, not only with emissions controls.

Source EPA Toxics Release Inventory (TRI)
Year Total Chemicals
2019 12.2K lbs 9
2020 13.9K lbs 8
2021 16.0K lbs 7
2022 16.0K lbs 7
2023 14.3K lbs 7

Chemical Releases

Aggregated across all reporting years (2019–2023). 2 of 10 chemicals are carcinogens. Sorted by total release volume.

Chemical Total Flags
Methanol 42.5K lbs -
n-Butyl alcohol 12.9K lbs -
Toluene 10.4K lbs -
Ammonia 4.6K lbs -
Acetonitrile 764 lbs -
Triethylamine 722 lbs -
Pyridine 465 lbs Carcinogen
Methyl tert-butyl ether 102 lbs -
Cyclohexane 43 lbs -
N,N-Dimethylformamide 30 lbs Carcinogen

Location

Coordinates
33.9815, -83.3313
ZIP Code
30601
EPA Facility ID
30603NRMCN1440O

About TRI Data

Data as of 2023 reporting year. Source: U.S. Environmental Protection Agency (EPA) Toxic Release Inventory.

Data comes from the EPA Toxic Release Inventory (TRI) program. Facilities that manufacture, process, or otherwise use listed toxic chemicals above threshold amounts are required to report annually to the EPA.

Release quantities are self-reported by the facility and may represent estimates rather than exact measurements. "Total releases" includes releases to air, water, land, and off-site transfers for disposal. Quantities shown here are aggregated across all available reporting years.

PlainEnviro presents this data without advocacy framing. The presence of a facility in the TRI database does not by itself indicate a health risk. For site-specific health questions, consult your local environmental or health agency.

Frequently Asked Questions

What chemicals does Janssen Pharmaceuticals Inc. release?
Janssen Pharmaceuticals Inc. has reported releases of 10 chemicals to the EPA Toxic Release Inventory, totaling 72.4K lbs. 2 of these (20%) are classified as carcinogens.
What industry is Janssen Pharmaceuticals Inc. in?
Janssen Pharmaceuticals Inc. is classified under the "Chemicals" industry (NAICS code 325411), located in Athens, GA.
How long has Janssen Pharmaceuticals Inc. reported to the TRI?
Janssen Pharmaceuticals Inc. has EPA Toxic Release Inventory data spanning 5 years, from 2019 to 2023.
How does Janssen Pharmaceuticals Inc. release toxic chemicals?
The primary release pathway for Janssen Pharmaceuticals Inc. is air releases, accounting for 100.0% of total releases (72.4K lbs).
Are emissions from Janssen Pharmaceuticals Inc. increasing or decreasing?
From 2019 to 2023, total releases increased by 17%, from 12.2K lbs to 14.3K lbs.
Is Janssen Pharmaceuticals Inc. a health risk?
The presence of a facility in the TRI database does not by itself indicate a health risk. Release quantities are self-reported estimates. For site-specific health questions, consult your local environmental or health agency.
Does Janssen Pharmaceuticals Inc. release carcinogens?
Yes, Janssen Pharmaceuticals Inc. reports 2 chemicals classified as carcinogens, representing 20% of all chemicals reported by this facility. Carcinogen classification is based on EPA and IARC assessments.

What to do with this facility's data

Use this facility profile as a starting point, then check how it compares.

  • See whether releases reported by Janssen Pharmaceuticals Inc. are rising or falling over time. View trends
  • This facility ranks #5,292 of 25,902 TRI facilities nationwide by total reported releases. Ranking reflects reported pounds, not toxicity or health risk. See the full rankings
  • Check Georgia's statewide profile for the full picture: total facilities, water systems, and Superfund sites. View Georgia profile

TRI release totals are self-reported estimates submitted to the EPA, not independently measured stack emissions; a high rank reflects reported volume, not necessarily local health risk.

Related

Sources & how this page was built

Every figure on this page traces to public, federal-government data on Janssen Pharmaceuticals Inc.. The records below are the primary sources; our methodology explains how they are joined, computed, and verified.

Retrieved and formatted by PlainEnviro Editorial. TRI release totals are self-reported estimates, not measured stack emissions.

According to the U.S. Environmental Protection Agency, the Toxics Release Inventory has required annual industrial disclosure since its creation under the Emergency Planning and Community Right-to-Know Act in October 1986, and this facility's record is drawn from PlainEnviro's database of more than 25,000 EPA-tracked facilities through the 2023 reporting year; see our methodology for full source citations and refresh cadence.